A Comparative, Randomized, Investigator-blind, Active-controlled, Parallel-group, Multicenter, Clinical Endpoint Study
Public ClinicalTrials.gov record NCT07661329. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Comparative Randomized, Investigator-Blind, Active-Controlled, Parallel-Group, Multicenter, Clinical Endpoint Study to Evaluate Efficacy and Safety of Bimatoprost Ophthalmic Solution 0.01% (YSBP) of YS Life Science Co., Ltd. (YSLS) and Lumigan® (Bimatoprost Ophthalmic Solution) 0.01% of AbbVie INC, in the Treatment of Subjects With Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OH).
Study identification
- NCT ID
- NCT07661329
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- YS Life Science Co., Ltd.
- Industry
- Enrollment
- 600 participants
Conditions and interventions
Interventions
- Bimatoprost ophthalmic solution 0.01% YSBP Drug
- bimatoprost ophthalmic solution 0.01% (Lumigan®) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 1, 2026
- Primary completion
- Oct 31, 2027
- Completion
- Dec 30, 2027
- Last update posted
- Jun 21, 2026
2026 – 2027
United States locations
- U.S. sites
- 16
- U.S. states
- 7
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| National Clinical Trials | Beverly Hills | California | 90210 | Not yet recruiting |
| United medical research institute | Inglewood | California | 90301 | Not yet recruiting |
| Eye research foundation, Inc. | Newport Beach | California | 92663 | Recruiting |
| Visionary Eye Research Institute | Newport Beach | California | 92663 | Not yet recruiting |
| North Bay Eye Associates | Petaluma | California | 94954 | Not yet recruiting |
| Advanced research, LLC | Boynton Beach | Florida | 33437 | Not yet recruiting |
| Quantum clinical trials | Miami Beach | Florida | 33140 | Not yet recruiting |
| Advanced research, LLC | Weston | Florida | 33326 | Not yet recruiting |
| Clayton Eye Clinical Research | Morrow | Georgia | 30260 | Not yet recruiting |
| Coastal Research Associates, LLC | Roswell | Georgia | 30076 | Not yet recruiting |
| The eye care institute | Louisville | Kentucky | 40206 | Not yet recruiting |
| Tekwani vision center | St Louis | Missouri | 63128 | Not yet recruiting |
| Ophthalmology associate (Eye care) | St Louis | Missouri | 63131 | Not yet recruiting |
| Rochester Ophthalmological Group | Rochester | New York | 14618 | Not yet recruiting |
| Houston Eye Associates | Houston | Texas | 77008 | Not yet recruiting |
| R and R eye research | San Antonio | Texas | 78229 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07661329, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 21, 2026 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07661329 live on ClinicalTrials.gov.